Natural Resource Partners L.P. Schedules First Quarter 2024 Earnings Conference Call
Get Alerts NRP Hot Sheet
Join SI Premium – FREE
HOUSTON--(BUSINESS WIRE)-- Natural Resource Partners L.P. (NYSE: NRP) plans to report its first quarter 2024 financial results before the market opens on Tuesday, May 7, 2024. Management will host a conference call beginning at 9:00 a.m. ET to discuss the results.
To register for the conference call please use this link https://registrations.events/direct/Q4I890960. After registering, a confirmation will be sent via email and include dial-in details and unique conference call codes for entry. Registration is open through the live call, however, to ensure you are connected for the full conference call we suggest registering a day in advance or at minimum 10 minutes before the start of the call. Investors may also listen to the conference call live via the Investor Relations section of the NRP website at www.nrplp.com.
Audio replays of the conference call will be available on the Investor Relations section of NRP’s website.
Company Profile
Natural Resource Partners L.P., a master limited partnership headquartered in Houston, TX, is a diversified natural resource company that owns, manages and leases a diversified portfolio of properties in the United States including coal, industrial minerals and other natural resources, as well as rights to conduct carbon sequestration and renewable energy activities. NRP also owns an equity investment in Sisecam Wyoming LLC, one of the world’s lowest-cost producers of soda ash.
Further information about NRP is available on the partnership’s website at http://www.nrplp.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240423359584/en/
Tiffany Sammis
Investor Relations
713.751.7515
[email protected]
Source: Natural Resource Partners L.P.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- AbelZeta Regains Global Rights of C-CAR039 (Prizlon-cel) and Receives FDA Clearance of IND Application in Large B-cell Lymphoma
- HUTCHMED Announces ORPATHYS® Plus TAGRISSO® Demonstrated Statistically Significant and Clinically Meaningful Improvements in Progression-Free and Overall Survival in MET-Driven EGFR-Mutated Lung Can
Create E-mail Alert Related Categories
Business Wire, Press ReleasesRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share